전체 논문 (29편 · 1/1)
-
Chronic graft-versus-host disease suppressing CD56Perforin regulatory-like NK cells inhibit CD4 T cells via PD-1, LAG-3, and TRAIL.
-
Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experience.
-
The emerging promise of induced pluripotent stem cells in clinical studies: a systematic scoping review of the literature and registered clinical trials.
-
Role of salvage allogeneic transplantation for relapsed or refractory AML in nonremission: insights from real-world practice.
-
Advancing acute myeloid leukemia immunotherapy: transcriptomic profiling-guided donor selection combined with an innovative natural killer cell expansion protocol.
-
Prognostic factors and outcomes of tisagenlecleucel in relapsed or refractory B-cell malignancies: a single-center real-world study.
-
Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantation.
-
GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemia.
-
Donor- and patient-derived interleukin 6 knockdown CD19-targeted chimeric antigen receptor T cells exhibit similar efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia patients after allogeneic hematopoietic stem cell transplantation.
-
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.
-
A FOXP3+ cell-rich microenvironment associates with better overall survival after CAR-T cell therapy in relapsed/refractory B-cell lymphoma.
-
Outcomes following hematopoietic cell transplantation for children, adolescents and young adults with relapsed acute lymphoblastic leukemia.
-
Impact of CD5 expression on outcomes for chimeric antigen receptor-T cell therapy in relapsed and refractory diffuse large B-cell lymphoma.
-
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registry.
-
Establishing practical predictors of collection efficiency for optimized chimeric antigen receptor T-cell apheresis.
-
Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphoma.
-
Allogeneic mesenchymal stromal cell therapy for nonregenerative anemia in a FeLV-infected cat: a case report.
-
Umbilical cord blood-derived natural killer cells as a viable and potent source for adoptive cell therapy.
-
Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy.
-
CD19 chimeric antigen receptor T-cell therapy for the treatment of a patient with refractory Burkitt lymphoma after kidney transplant.
-
Endothelial activation and stress index (EASIX) score is a stronger predictor of survival after allogeneic hematopoietic stem cell transplantation than acute-phase biomarkers.
-
Optimizing the timing of lymphocyte collection after stem cell harvesting in B-cell lymphoma and myeloma patients.
-
Long-term follow-up of CD19 chimeric antigen receptor T cell therapy in acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation.
-
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.
-
A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancer.
-
Adipose tissue and the vascularization of biomaterials: Stem cells, microvascular fragments and nanofat-a review.
-
Ultrasound-assisted liposuction provides a source for functional adipose-derived stromal cells.
-
Enrichment isolation of adipose-derived stem/stromal cells from the liquid portion of liposuction aspirates with the use of an adherent column.
-
Human adipose stromal vascular cell delivery in a fibrin spray.